These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 25192338)

  • 21. Effect of the timing of antiretroviral treatment initiation on CD4 count in children and youths living with HIV in North India.
    Singh MV; Sharma S; Shrivastava A; Shukla SK; Siddiqui SA; Maurya M; Mishra N; Yadav RK
    Int J STD AIDS; 2024 Apr; 35(5):389-396. PubMed ID: 38214670
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessing the impact of antiretroviral therapy on tuberculosis notification rates among people with HIV: a descriptive analysis of 23 countries in sub-Saharan Africa, 2010-2015.
    Surie D; Borgdorff MW; Cain KP; Click ES; DeCock KM; Yuen CM
    BMC Infect Dis; 2018 Sep; 18(1):481. PubMed ID: 30257667
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Delivery of antiretroviral treatment services in India: Estimated costs incurred under the National AIDS Control Programme.
    Agarwal R; Rewari BB; Shastri S; Nagaraja SB; Rathore AS
    WHO South East Asia J Public Health; 2017 Apr; 6(1):94-98. PubMed ID: 28597866
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Community and service provider views to inform the 2013 WHO consolidated antiretroviral guidelines: key findings and lessons learnt.
    Hsieh AC; Mburu G; Garner AB; Teltschik A; Ram M; Mallouris C; Penazzato M; Shaffer N; Easterbrook PJ; Ball A
    AIDS; 2014 Mar; 28 Suppl 2():S205-16. PubMed ID: 24849480
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Screening and testing for tuberculosis among the HIV-infected: outcomes from a large HIV programme in western Kenya.
    Owiti P; Onyango D; Momanyi R; Harries AD
    BMC Public Health; 2019 Jan; 19(1):29. PubMed ID: 30621655
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The journey to antiretroviral therapy in Karnataka, India: who was lost on the road?
    Shastri S; Sathyanarayna S; Nagaraja SB; Kumar AM; Rewari B; Harries AD; Zachariah R
    J Int AIDS Soc; 2013 Aug; 16(1):18502. PubMed ID: 23985346
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiretroviral use during pregnancy for treatment or prophylaxis.
    Sturt AS; Read JS
    Expert Opin Pharmacother; 2011 Aug; 12(12):1875-85. PubMed ID: 21534886
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of diabetes mellitus and hypertension in people living with human immunodeficiency virus on antiretroviral therapy in Gweru district, Zimbabwe.
    Gonah L; Moodley I; Hlongwana K
    Afr J Prim Health Care Fam Med; 2020 Aug; 12(1):e1-e6. PubMed ID: 32787407
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Towards achieving the 90-90-90 HIV targets: results from the south African 2017 national HIV survey.
    Marinda E; Simbayi L; Zuma K; Zungu N; Moyo S; Kondlo L; Jooste S; Nadol P; Igumbor E; Dietrich C; Briggs-Hagen M
    BMC Public Health; 2020 Sep; 20(1):1375. PubMed ID: 32907565
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thrombocytopenia according to antiretroviral drug combinations, viremia and CD4 lymphocytes among HIV-infected patients in Cameroon: a snapshot from the City of Yaoundé.
    Nka AD; Sosso SM; Fokam J; Bouba Y; Teto G; Simo Rachel R; Tiga A; Yimga J; Nukenine EN; Nanfack AJ; Takou D; Aroga Z; Colizzi V; Ndjolo A
    BMC Res Notes; 2019 Sep; 12(1):632. PubMed ID: 31554515
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors Influencing Adherence to Antiretroviral Therapy among People Living with HIV in Coastal South India.
    Banagi Yathiraj A; Unnikrishnan B; Ramapuram JT; Kumar N; Mithra P; Kulkarni V; Holla R; Darshan B; Thapar R
    J Int Assoc Provid AIDS Care; 2016 Nov; 15(6):529-533. PubMed ID: 27493025
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Access to antiretroviral therapy and survival in eastern Europe and central Asia: a case study in Armenia.
    Mallitt KA; Grigoryan SR; Papoyan AS; Wand HC; Wilson DP
    J Int AIDS Soc; 2014; 17(1):18795. PubMed ID: 25095830
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early-phase scale-up of isoniazid preventive therapy for people living with HIV in two districts in Malawi (2017).
    Nabity SA; Gunde LJ; Surie D; Shiraishi RW; Kirking HL; Maida A; Auld AF; Odo M; Jahn A; Nyirenda RK; Oeltmann JE
    PLoS One; 2021; 16(4):e0248115. PubMed ID: 33793577
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of WHO guidelines on trends in HIV testing and ART initiation among children living with HIV in Zambia.
    Munthali T; Michelo C; Mee P; Moyo C; Kashoka A; Liswaniso L; Chiboma I; Todd J
    AIDS Res Ther; 2020 May; 17(1):18. PubMed ID: 32408890
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discordance between CD4 cell count and CD4 cell percentage: implications for when to start antiretroviral therapy in HIV-1 infected children.
    ; Boyd K; Dunn DT; Castro H; Gibb DM; Duong T; Aboulker JP; Bulterys M; Cortina-Borja M; Gabiano C; Galli L; Giaquinto C; Harris DR; HugheS M; McKinney R; Mofenson L; Moye J; Newell ML; Pahwa S; Palumbo P; Rudin C; Sharland M; Shearer W; Thompson B; Tookey P
    AIDS; 2010 May; 24(8):1213-7. PubMed ID: 20386428
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Progress in Reversing the HIV Epidemic through Intensified Access to Antiretroviral Therapy: Results from a Nationally Representative Population-Based Survey in Kenya, 2012.
    Kim AA; Mukui I; N'gan'ga L; Katana A; Koros D; Wamicwe J; De Cock KM;
    PLoS One; 2016; 11(3):e0148068. PubMed ID: 26930291
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa.
    ; Danel C; Moh R; Gabillard D; Badje A; Le Carrou J; Ouassa T; Ouattara E; Anzian A; Ntakpé JB; Minga A; Kouame GM; Bouhoussou F; Emieme A; Kouamé A; Inwoley A; Toni TD; Ahiboh H; Kabran M; Rabe C; Sidibé B; Nzunetu G; Konan R; Gnokoro J; Gouesse P; Messou E; Dohoun L; Kamagate S; Yao A; Amon S; Kouame AB; Koua A; Kouamé E; Ndri Y; Ba-Gomis O; Daligou M; Ackoundzé S; Hawerlander D; Ani A; Dembélé F; Koné F; Guéhi C; Kanga C; Koule S; Séri J; Oyebi M; Mbakop N; Makaila O; Babatunde C; Babatounde N; Bleoué G; Tchoutedjem M; Kouadio AC; Sena G; Yededji SY; Assi R; Bakayoko A; Mahassadi A; Attia A; Oussou A; Mobio M; Bamba D; Koman M; Horo A; Deschamps N; Chenal H; Sassan-Morokro M; Konate S; Aka K; Aoussi E; Journot V; Nchot C; Karcher S; Chaix ML; Rouzioux C; Sow PS; Perronne C; Girard PM; Menan H; Bissagnene E; Kadio A; Ettiegne-Traore V; Moh-Semdé C; Kouame A; Massumbuko JM; Chêne G; Dosso M; Domoua SK; N'Dri-Yoman T; Salamon R; Eholié SP; Anglaret X
    N Engl J Med; 2015 Aug; 373(9):808-22. PubMed ID: 26193126
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trends in and correlates of CD4+ cell count at antiretroviral therapy initiation after changes in national ART guidelines in Rwanda.
    Mutimura E; Addison D; Anastos K; Hoover D; Dusingize JC; Karenzie B; Izimukwiye I; Mutesa L; Nsanzimana S; Nash D;
    AIDS; 2015 Jan; 29(1):67-76. PubMed ID: 25562492
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Virological and Immunological Status of the People Living with HIV/AIDS Undergoing ART Treatment in Nepal.
    Ojha CR; Shakya G; Dumre SP
    Biomed Res Int; 2016; 2016():6817325. PubMed ID: 27547761
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The impact of antiretroviral therapy in resource-limited settings and current HIV therapeutics.
    Kumarasamy N
    Oral Dis; 2016 Apr; 22 Suppl 1():42-5. PubMed ID: 27109271
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.